| Shareholder | |||
|---|---|---|---|
| ZHANG JunfengExecutive Director | 40.62% | 287.40M | |
| ZHANG XiaoliExecutive Director | 40.62% | 287.40M | |
| ZHANG BozhouExecutive Director | 40.62% | 287.39M | |
| Zhang Hongbo | 40.43% | 286.06M | |
| He Yong | 40.43% | 286.06M | |
| Zhang Fengsheng | 40.43% | 286.06M | |
| Li Furong | 40.43% | 286.06M | |
| Su Yuqin | 40.43% | 286.06M | |
| Zhang Yumei | 40.43% | 286.06M | |
| Jin Longqi | 40.43% | 286.06M | |
| AREO HOLDINGS LIMITED | 12.01% | 84.95M | |
| LAM LAI MING | 12.01% | 84.95M | |
| LI GABRIEL | 12.01% | 84.95M | |
| Liu Linan | 11.42% | 78.54M | |
| Guangming Medical Management Co. Limited | 8.72% | 59.97M | |
| 厦门朝翕企业管理咨询合伙企业(有限合伙) | 5.93% | 41.96M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of CHAOJU EYE CARE (02219) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

